These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7938561)

  • 1. The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania.
    Kanba S; Yagi G; Kamijima K; Suzuki T; Tajima O; Otaki J; Arata E; Koshikawa H; Nibuya M; Kinoshita N
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):707-15. PubMed ID: 7938561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial.
    McElroy SL; Suppes T; Keck PE; Black D; Frye MA; Altshuler LL; Nolen WA; Kupka RW; Leverich GS; Walden J; Grunze H; Post RM
    J Clin Psychiatry; 2005 May; 66(5):617-24. PubMed ID: 15889949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is adjunctive open-label zonisamide effective for bipolar disorder?
    Ghaemi SN; Shirzadi AA; Klugman J; Berv DA; Pardo TB; Filkowski MM
    J Affect Disord; 2008 Jan; 105(1-3):311-4. PubMed ID: 17586053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zonisamide-induced psychosis in a patient with bipolar disorder and narcolepsy.
    Platt JE; Opler LA; Platt EM
    Am J Ther; 2014; 21(3):e88-9. PubMed ID: 22713527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preliminary open-label study of zonisamide treatment for bipolar depression in 10 patients.
    Anand A; Bukhari L; Jennings SA; Lee C; Kamat M; Shekhar A; Nurnberger JI; Lightfoot J
    J Clin Psychiatry; 2005 Feb; 66(2):195-8. PubMed ID: 15705004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open prospective study of zonisamide in acute bipolar depression.
    Ghaemi SN; Zablotsky B; Filkowski MM; Dunn RT; Pardo TB; Isenstein E; Baldassano CF
    J Clin Psychopharmacol; 2006 Aug; 26(4):385-8. PubMed ID: 16855456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Third generation anticonvulsants in bipolar disorder: a review of efficacy and summary of clinical recommendations.
    Yatham LN; Kusumakar V; Calabrese JR; Rao R; Scarrow G; Kroeker G
    J Clin Psychiatry; 2002 Apr; 63(4):275-83. PubMed ID: 12000201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cautionary note when using zonisamide in youths: a case report of association with toxic epidermal necrolysis.
    Majeres KD; Suppes T
    J Clin Psychiatry; 2004 Dec; 65(12):1720. PubMed ID: 15641880
    [No Abstract]   [Full Text] [Related]  

  • 9. Zonisamide versus diazepam in the treatment of alcohol withdrawal syndrome.
    Rubio G; López-Muñoz F; Ponce G; Pascual JM; Martínez-Gras I; Ferre F; Jiménez-Arriero MÁ; Alamo C
    Pharmacopsychiatry; 2010 Nov; 43(7):257-62. PubMed ID: 20927698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zonisamide for bipolar depression.
    Wilson MS; Findling RL
    Expert Opin Pharmacother; 2007 Jan; 8(1):111-3. PubMed ID: 17163811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: results of a phase III, randomized, double-blind study.
    Baulac M; Patten A; Giorgi L
    Epilepsia; 2014 Oct; 55(10):1534-43. PubMed ID: 25109239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zonisamide-induced mania in an essential tremor patient.
    Sullivan KL; Ward CL; Zesiewicz TA
    J Clin Psychopharmacol; 2006 Aug; 26(4):439-40. PubMed ID: 16855471
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized, placebo-controlled study of zonisamide to prevent olanzapine-associated weight gain.
    McElroy SL; Winstanley E; Mori N; Martens B; McCoy J; Moeller D; Guerdjikova AI; Keck PE
    J Clin Psychopharmacol; 2012 Apr; 32(2):165-72. PubMed ID: 22367654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newer anticonvulsants in the treatment of bipolar disorder.
    Yatham LN
    J Clin Psychiatry; 2004; 65 Suppl 10():28-35. PubMed ID: 15242330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder.
    Calabrese JR; Bowden CL; McElroy SL; Cookson J; Andersen J; Keck PE; Rhodes L; Bolden-Watson C; Zhou J; Ascher JA
    Am J Psychiatry; 1999 Jul; 156(7):1019-23. PubMed ID: 10401445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zonisamide in epilepsy: a pilot study.
    Wilensky AJ; Friel PN; Ojemann LM; Dodrill CB; McCormick KB; Levy RH
    Epilepsia; 1985; 26(3):212-20. PubMed ID: 4006880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zonisamide treatment of bipolar disorder: a case report.
    Berigan TR
    Can J Psychiatry; 2002 Nov; 47(9):887. PubMed ID: 12500762
    [No Abstract]   [Full Text] [Related]  

  • 18. Phenytoin as an antimanic anticonvulsant: a controlled study.
    Mishory A; Yaroslavsky Y; Bersudsky Y; Belmaker RH
    Am J Psychiatry; 2000 Mar; 157(3):463-5. PubMed ID: 10698828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zonisamide in pediatric epilepsy: review of the Japanese experience.
    Glauser TA; Pellock JM
    J Child Neurol; 2002 Feb; 17(2):87-96. PubMed ID: 11952083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of zonisamide in patients with chronic pain or epilepsy refractory to other treatments: a retrospective, open label, uncontrolled study in a VA hospital.
    Hasegawa H
    Curr Med Res Opin; 2004 May; 20(5):577-80. PubMed ID: 15140322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.